The opportunity for biotechs in precision medicine
Within the past 20 years, the field of precision medicine has been transformed. For biotech companies, this new landscape holds tremendous promise for innovation. So, why aren’t more companies leveraging this approach? In this episode, Parexel precision medicine experts Angela Qu and Arlene Hughes join host Alberto Grignolo to discuss this conundrum, and what biotechs should be thinking about right from the start, to open up the opportunity for this approach to help bring innovation and new therapies to more patients.
Related Insights
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Article
How RWE can help Biotechs optimize the value of their asset
Apr 5, 2021
Article
Guide for Real-World Evidence
May 21, 2021
Podcast
Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Podcast
De-risking Drug Development | Episode 1: How to drive value in pre-clinical development
May 28, 2024
Video
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022
Webinar
Leveraging post-marketing regulatory requirements to drive commercial value
Oct 16, 2024
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Blog
Three Ways Early-Stage Companies Can Attract Investors
Feb 3, 2022
Podcast
Funding Biotech Innovation: How to Attract Investors
Jan 18, 2022
Article
How emerging biotechs can enter the Chinese market and prosper
Jan 18, 2022
Related Insights
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Article
How RWE can help Biotechs optimize the value of their asset
Apr 5, 2021
Article
Guide for Real-World Evidence
May 21, 2021
Podcast
Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Podcast
De-risking Drug Development | Episode 1: How to drive value in pre-clinical development
May 28, 2024
Video
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022
Webinar
Leveraging post-marketing regulatory requirements to drive commercial value
Oct 16, 2024
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Blog
Three Ways Early-Stage Companies Can Attract Investors
Feb 3, 2022
Podcast
Funding Biotech Innovation: How to Attract Investors
Jan 18, 2022
Article
How emerging biotechs can enter the Chinese market and prosper
Jan 18, 2022